BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30858407)

  • 21. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.
    Osswald M; Blaes J; Liao Y; Solecki G; Gömmel M; Berghoff AS; Salphati L; Wallin JJ; Phillips HS; Wick W; Winkler F
    Clin Cancer Res; 2016 Dec; 22(24):6078-6087. PubMed ID: 27521448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of stat3 in human melanoma promotes brain metastasis.
    Xie TX; Huang FJ; Aldape KD; Kang SH; Liu M; Gershenwald JE; Xie K; Sawaya R; Huang S
    Cancer Res; 2006 Mar; 66(6):3188-96. PubMed ID: 16540670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response.
    Bernhardt M; Novak D; Assenov Y; Orouji E; Knappe N; Weina K; Reith M; Larribere L; Gebhardt C; Plass C; Umansky V; Utikal J
    Stem Cell Reports; 2017 May; 8(5):1379-1391. PubMed ID: 28392221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
    Murrell J; Board R
    Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
    Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
    Biroccio A; Amodei S; Benassi B; Scarsella M; Cianciulli A; Mottolese M; Del Bufalo D; Leonetti C; Zupi G
    Oncogene; 2002 May; 21(19):3011-9. PubMed ID: 12082531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AKT1 Activation Promotes Development of Melanoma Metastases.
    Cho JH; Robinson JP; Arave RA; Burnett WJ; Kircher DA; Chen G; Davies MA; Grossmann AH; VanBrocklin MW; McMahon M; Holmen SL
    Cell Rep; 2015 Nov; 13(5):898-905. PubMed ID: 26565903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly pigmented human melanoma variant which metastasizes widely in nude mice, including to skin and brain.
    Ishikawa M; Fernandez B; Kerbel RS
    Cancer Res; 1988 Sep; 48(17):4897-903. PubMed ID: 3409224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells.
    Scaini MC; Pigozzo J; Pizzi M; Manicone M; Chiarion-Sileni V; Zambenedetti P; Rugge M; Zanovello P; Rossi E; Zamarchi R; Facchinetti A
    Melanoma Res; 2019 Feb; 29(1):89-94. PubMed ID: 30222690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VLA-4 mediated adhesion of melanoma cells on the blood-brain barrier is the critical cue for melanoma cell intercalation and barrier disruption.
    García-Martín AB; Zwicky P; Gruber T; Matti C; Moalli F; Stein JV; Francisco D; Enzmann G; Levesque MP; Hewer E; Lyck R
    J Cereb Blood Flow Metab; 2019 Oct; 39(10):1995-2010. PubMed ID: 29762071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
    Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
    Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility-weighted imaging in malignant melanoma brain metastasis.
    Schwarz D; Niederle T; Münch P; Hielscher T; Hassel JC; Schlemmer HP; Platten M; Winkler F; Wick W; Heiland S; Delorme S; Bendszus M; Bäumer P; Breckwoldt MO
    J Magn Reson Imaging; 2019 Oct; 50(4):1251-1259. PubMed ID: 30793419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
    Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
    Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
    Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
    J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.
    Civenni G; Walter A; Kobert N; Mihic-Probst D; Zipser M; Belloni B; Seifert B; Moch H; Dummer R; van den Broek M; Sommer L
    Cancer Res; 2011 Apr; 71(8):3098-109. PubMed ID: 21393506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice.
    Kerbel RS; Man MS; Dexter D
    J Natl Cancer Inst; 1984 Jan; 72(1):93-108. PubMed ID: 6582307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
    J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biology and therapeutic management of melanoma brain metastases.
    Abate-Daga D; Ramello MC; Smalley I; Forsyth PA; Smalley KSM
    Biochem Pharmacol; 2018 Jul; 153():35-45. PubMed ID: 29278675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo.
    Sahranavardfard P; Firouzi J; Azimi M; Khosravani P; Heydari R; Emami Razavi A; Dorraj M; Keighobadi F; Ebrahimi M
    J Cell Physiol; 2019 Nov; 234(11):20193-20205. PubMed ID: 31016725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.